UiPath Inc. (NYSE:PATH) Shares Purchased by AdvisorNet Financial Inc

AdvisorNet Financial Inc raised its position in shares of UiPath Inc. (NYSE:PATHGet Rating) by 48.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,120 shares of the healthcare company’s stock after buying an additional 1,020 shares during the quarter. AdvisorNet Financial Inc’s holdings in UiPath were worth $57,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of PATH. Private Advisor Group LLC acquired a new stake in UiPath during the fourth quarter valued at approximately $372,000. Charles Schwab Investment Management Inc. raised its position in shares of UiPath by 3.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 756,868 shares of the healthcare company’s stock worth $32,644,000 after purchasing an additional 25,532 shares during the period. Geode Capital Management LLC raised its position in shares of UiPath by 4.4% during the 4th quarter. Geode Capital Management LLC now owns 2,164,082 shares of the healthcare company’s stock worth $93,336,000 after purchasing an additional 90,485 shares during the period. Gotham Asset Management LLC acquired a new stake in shares of UiPath during the 4th quarter worth approximately $217,000. Finally, Rockefeller Capital Management L.P. raised its position in shares of UiPath by 132.9% during the 4th quarter. Rockefeller Capital Management L.P. now owns 6,688 shares of the healthcare company’s stock worth $287,000 after purchasing an additional 3,816 shares during the period. Institutional investors and hedge funds own 51.35% of the company’s stock.

Wall Street Analysts Forecast Growth

PATH has been the topic of a number of research reports. Wells Fargo & Company dropped their price target on UiPath from $30.00 to $22.00 and set an “overweight” rating on the stock in a research report on Wednesday, September 7th. Royal Bank of Canada dropped their price target on UiPath from $22.00 to $18.00 in a research report on Wednesday, September 7th. Truist Financial dropped their price target on UiPath from $45.00 to $25.00 and set a “buy” rating on the stock in a research report on Wednesday, September 7th. Mizuho cut UiPath from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $40.00 to $14.00 in a research report on Wednesday, September 7th. Finally, Morgan Stanley cut UiPath from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $32.00 to $15.00 in a research report on Wednesday, September 7th. Seven research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $24.97.

UiPath Stock Performance

Shares of NYSE PATH opened at $13.04 on Friday. The stock has a fifty day moving average price of $17.67 and a two-hundred day moving average price of $19.67. The firm has a market cap of $7.10 billion, a P/E ratio of -16.30 and a beta of 0.11. UiPath Inc. has a 1 year low of $12.21 and a 1 year high of $59.57.

UiPath (NYSE:PATHGet Rating) last released its quarterly earnings data on Tuesday, September 6th. The healthcare company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.09. The business had revenue of $242.22 million during the quarter, compared to analyst estimates of $230.68 million. UiPath had a negative return on equity of 19.19% and a negative net margin of 42.98%. The company’s revenue was up 23.9% compared to the same quarter last year. During the same period last year, the company posted ($0.17) EPS. On average, research analysts predict that UiPath Inc. will post -0.63 earnings per share for the current fiscal year.

Insider Transactions at UiPath

In other news, CFO Ashim Gupta sold 100,000 shares of the firm’s stock in a transaction on Monday, August 15th. The stock was sold at an average price of $20.70, for a total transaction of $2,070,000.00. Following the completion of the sale, the chief financial officer now directly owns 1,387,266 shares of the company’s stock, valued at approximately $28,716,406.20. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, CFO Ashim Gupta sold 100,000 shares of the firm’s stock in a transaction on Monday, August 15th. The stock was sold at an average price of $20.70, for a total value of $2,070,000.00. Following the completion of the sale, the chief financial officer now owns 1,387,266 shares of the company’s stock, valued at $28,716,406.20. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CAO Hitesh Ramani sold 22,800 shares of the firm’s stock in a transaction on Monday, August 15th. The stock was sold at an average price of $20.70, for a total value of $471,960.00. Following the completion of the sale, the chief accounting officer now directly owns 426,799 shares of the company’s stock, valued at approximately $8,834,739.30. The disclosure for this sale can be found here. Insiders sold a total of 162,800 shares of company stock valued at $3,129,960 in the last three months. 31.88% of the stock is currently owned by corporate insiders.

UiPath Profile

(Get Rating)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Stories

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATHGet Rating).

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.